Friday, March 06, 2020

Research shows how physical cues drive cell migration, cancer metastasis, and treatment

Cancer cells are a product of their environment. The surrounding cells, extracellular matrix, and other features influence disease progression and spread of cancer cells to other parts of the body. Chemical cues like the presence of nutrients and oxygen have been studied for decades, but more recently, researchers have turned their attention to equally important physical cues.

New research on the tumor mechanical microenvironment will be presented at the 2020 American Physical Society March Meeting in Denver. Highlights include a study that looks at how the anisotropy of the extracellular matrix affects cancer cell migration, a novel optical tweezer-based tool that probes mechanical cues, and a model to find the best place within a tumor to inject a chemotherapy drug.


Mechanical cues drive metastasis

Oregon State University researcher Bo Sun will present his findings on the complex interactions between cancer cell migration and the extracellular matrix, a 3D network of collagen, proteins, and other molecules that support the surrounding cells. Specifically, he will discuss the anisotropy of the extracellular matrix, and how a particular alignment of collagen fibers can create a cancer cell superhighway of sorts.

For most research in the field so far, a dominant paradigm is that rigidity of the tissue environment is the dominant factor that guides cell migration. The cell wants to move to a more rigid region compared to a soft region. We're seeing that a different type of physical property, anisotropy of the environment, is more efficient in terms of guiding cell migration."    Bo Sun, Oregon State University researcher

For instance, collagen fibers aligned circumferentially around the tumor causes the cancer cells to become trapped by this alignment, whereas fibers arranged radially provide a frictionless highway for cells to migrate outward. Studying the way cells move in their environment--and what factors drive that movement--has implications for understanding how cancer cells infiltrate new areas of the body.


Probing tissues with optical tweezers

Biophysicist Kandice Tanner has repurposed a tool to measure the mechanical cues that may influence how tumor cells disseminate to different organs. The optical tweezer-based technique can probe the physical properties of cells in living animals with microscale resolution.

"Previously, characterization of mechanical properties of tissues, cells, and extracellular matrix hydrogels were mainly obtained using bulk rheological or nanometer scale techniques such as atomic force microscopy and primarily for in vitro systems," said Tanner, an investigator at the National Cancer Institute, part of the National Institutes of Health. "These techniques are useful to assess material properties but do not possess the resolution that is needed to resolve length scales that are compatible with the micron-size protrusions used by cells to respond to external cues."

Tanner and her colleagues employed the technique to measure the viscoelastic properties of tissue in living zebrafish and 3D culture models of breast cancer progression. For the latter project, they used optical trap-based active microrheology to map internal cellular and external extracellular matrix mechanics with near simultaneity. They found that, unlike healthy cells, breast tumor cells do not match their mechanical properties to the surrounding microenvironment.


As cancer cells migrate from their original primary tumor, they encounter many physical cues before establishing new lesions in different organs such as the patient's bones, brain, liver, or lungs," said Tanner. "We believe that by decoding the role of the physical cues, we can understand why some tumor cells are able to colonize one organ versus the other."


Shapeshifting cells

While the extracellular matrix simulated in lab experiments is almost purely elastic--it bounces back to its original form once a stress is removed--the scaffolding in the brain, liver, and other tissues is not. In these regions, the extracellular matrix exhibits both viscous and elastic characteristics. Harvard researcher Anupam Gupta will present his research on how viscoelastic properties of the extracellular matrix can transform normal cells into cancer cells.

Gupta and his colleagues have observed that increasing the fluidic nature of the extracellular matrix causes normal breast cells to lose their spherical shape, form a rough interface, and develop fingers. Based on these results, they created a mathematical model of the cell mechanics that shows finger formation stops with increasing viscosity or elasticity.


Modeling cancer drug response

Cancer treatment relies heavily on trial and error, which can lead to unnecessary toxicity and cost. Models that predict how a cancer drug will diffuse throughout the tumor offer a possible solution for oncologists. Aminur Rahman develops these kinds of mechanistic models of drug response as a method for oncologists to choose the most effective treatment before administering any medication.

"Our mechanistic models are able to produce dose-response curves that oncologists would see from cell line and drug data pairs," said Rahman, a post-doctoral researcher at Texas Tech University. "We realized that perhaps this research could be used for computer-aided treatment strategies."

He will present the results of multiple projects in a poster presentation. The first investigates a model of drug distribution after injection directly into a solid tumor and its effect on cancer cell death. While the model assumes the tumor is spherical and homogeneous, brain tumors in particular tend to be highly inhomogeneous and anisotropic. The second study develops a more sophisticated computational model for inhomogeneous-anisotropic drug diffusion using real-world diffusion tensor MRI data.

"Because of the tumor's inhomogeneity and anisotropy, the center might not be the best place to inject drugs," said Rahman. "We looked at different injection sites, and it was not necessary the center that would do the trick. In such cases, having a model would help an oncologist know where to inject the drug."


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , ,

Friday, February 21, 2020

Supersensitive nanomaterials hold promise for DNA analysis and next-generation drugs

In 1900, German physician Paul Ehrlich came up with the notion of a "magic bullet." The basic idea is to inject a patient with smart particles capable of finding, recognizing, and treating disease. Medicine has pursued the magic bullet ever since.

Russian researchers from the Moscow Institute of Physics and Technology and Prokhorov General Physics Institute, RAS, have made headway toward that goal. Led by MIPT's Maxim Nikitin, the team published a paper in ACS Nano (impact factor: 13.903), presenting a smart material with unique properties, which holds promise for express DNA analysis and next-generation drugs against cancer and other serious diseases.

Delivering medications to the cells affected by a disease is a major bottleneck in diagnostics and therapy. The drugs should ideally reach the pathogenic cells only, without doing any harm to the healthy ones. There are a range of marker compounds that give away cancer cells. Among these telltale molecules, found on the surface of the affected cells or in their microenvironment, are waste products and those sent to other cells as signals.

Modern drugs rely on one such marker to identify sick cells. However,it is usually the case that healthy cells carry the same markers, albeit in smaller quantities. This means the existing targeted drug delivery systems are not perfect. To make drug delivery more specific, smart materials are required that are capable of analyzing multiple environment parameters at once, seeking out the target with a greater precision.

The conventionally used methods for drug delivery are like sending a letter with the city and street written on the envelope, but without the house and apartment numbers. We need to be able to analyze more parameters to ensure effective delivery."Maxim Nikitin, principal investigator and the head of MIPT's Nanobiotechnology Lab 

Previously, Nikitin and co-authors developed nano- and microparticles capable of conducting complex logic computations via biochemical reactions. In their 2014 paper in Nature Nanotechnology, the researchers reported that their autonomous nanocomputers could analyze many parameters of a target and were therefore much better at its identification.

The past few years have seen many advances in biocomputing materials. By 2018, hundreds upon hundreds of papers had been published on the subject. Chemical Reviews, the field's most reputable journal with an impact factor of 54.301, published a review of contemporary nanorobotics and biocomputing. The paper, with the subtitle "Dawn of Theranostic Nanorobots," was authored by researchers from MIPT's Nanobiotechnology Lab and the Biophotonics Lab of Prokhorov General Physics Institute of the Russian Academy of Sciences (RAS).

Despite the efforts of numerous research teams around the world trying to expand the functionality of biocomputing materials, they are still not sensitive enough to disease markers, rendering practical applications impossible.

The recent paper of the team in ACS Nano marks a breakthrough in this field. They have developed a unique smart material characterized by supersensitivity to DNA signals. It is several orders of magnitude more sensitive than the closest competitor. Moreover, the new material exhibits a higher sensitivity than that of the vast majority of currently available express DNA assays.

The researchers achieved that remarkable result after they discovered that DNA molecules exhibit unusual behavior on the surface of nanoparticles.

In the study, one end of a single-stranded DNA molecule was pinned to a nanoparticle. Importantly, the molecule had no hairpins -- that is, double-stranded segments where part of the chain sticks to itself. The team outfitted the other end of the DNA chain with a small molecular receptor. Contrary to expectations, the receptor did not bind its target. After ruling out a mistake, the scientists hypothesized that single-stranded DNA might stick to the nanoparticle and coil up, hiding the receptor beneath it, on the particle's surface.

The hypothesis proved right when the team added complementary single strands of DNA to their particle. The receptor instantly became active, binding its target. This happened because the bonds between the complementary nucleotides caused the two DNA strands to form a rigid double helix, or duplex. Like a chameleon's tongue, the strand uncoiled, exposing the receptor for target binding.

Such uncoiling of the DNA strand resembles that of a molecular beacon. This refers to a single-stranded DNA whose one end forms a duplex with the opposite end, folding up the structure. A complementary strand of DNA can unfold the beacon. However, there is a significant and useful distinction. "Unlike molecular beacons, the discovered phenomenon enables tuning the force of DNA curling on the nanoparticle separately from the straightening force of input DNA. This leads to dramatically better sensitivity to the input," noted the study's first author Vladimir Cherkasov, a leading researcher at the Nanobiotechnology Lab, MIPT.

In their paper, the researchers demonstrate agents capable of detecting DNA concentrations as low as 30 femtomoles (30 billionths of a millionth of a mole) per liter, without DNA and/or signal amplification. The study's co-author Elizaveta Mochalova, a doctoral student at MIPT's Nanobiotechnology Lab, added: "We showed the sensitivity to be so high with a quite simple lateral flow assay, which is widely used in pregnancy tests. Unlike the existing DNA assays, such tests can be performed outside a clean laboratory setting and require no advanced equipment. This makes the technology well-suited to rapid infectious disease screening, food testing kits for home use, and similar things."

The authors of the paper have also showed the technology to be applicable to the design of smart nanoagents that would recognize cancer cells based on the concentration of small DNA in their microenvironment. Not long ago, small nucleic acids were thought to be just meaningless debris resulting from the recycling of larger functional molecules. However, small RNAs turned out to be key regulators of many processes in living cells. Biologists are currently identifying disease markers among these RNAs.

"Interestingly, the smaller the length of the nucleic acid to be detected, the more competitive our technology becomes," Nikitin commented. "We can fabricate ultrasensitive agents controlled by well-studied small RNAs that are 17 to 25 bases long. However, if we take sequences that are less than 10 nucleotides long, there are simply no technologies with comparable sensitivity."

"What's even more exciting is that our method enables probing the microenvironment of cells to determine whether shorter small RNAs are useful disease markers rather than the meaningless compounds they are commonly held to be due to the difficulties in their detection," the scientist added.

The newly developed technology offers prospects for genomics, both in terms of express point-of-care DNA assays and for developing next-generation therapeutic nanomaterials. The recent years have seen immense breakthroughs in genome research and editing, but the new technology could solve the problem that remains relevant: delivering drugs only to the cells with a particular microenvironment genetic profile.

The researchers plan to continue developing their technology. This includes future work at MIPT's recently established Center for Genomic Technologies and Bioinformatics.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , , ,